U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Femoropopliteal Occlusive Disease

MedGen UID:
272629
•Concept ID:
C1333606
•
Disease or Syndrome

Definition

An occlusive disease of the femoropopliteal vascular system. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVFemoropopliteal Occlusive Disease

Professional guidelines

PubMed

Midterm Results of the Supera Stent for the Treatment of Femoropopliteal Occlusive Disease.
Low J, Shih T, Lu E, Derubertis BG, Baril DT
Ann Vasc Surg 2022 Oct;86:177-183. Epub 2022 Jun 29 doi: 10.1016/j.avsg.2022.05.031. PMID: 35779806
Clinical Outcomes after Endovascular Treatment Failure in Patients with Femoropopliteal Occlusive Disease.
Hernández Mateo MM, Martínez López I, Revuelta Suero S, Marqués de Marino P, Cernuda Artero I, Cabrero Fernández M, Serrano Hernando FJ
Ann Vasc Surg 2016 Jan;30:299-304. Epub 2015 Nov 2 doi: 10.1016/j.avsg.2015.07.039. PMID: 26541966
Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis.
Mwipatayi BP, Hockings A, Hofmann M, Garbowski M, Sieunarine K
J Vasc Surg 2008 Feb;47(2):461-9. Epub 2007 Oct 22 doi: 10.1016/j.jvs.2007.07.059. PMID: 17950563

Recent clinical studies

Etiology

Short-Term Outcomes After Retrograde Versus Antegrade Crossing Approaches for Femoropopliteal Occlusive Disease.
Meadors S, Klein A, Jeon-Slaughter H, Jawaid O, Armstrong EJ, Banerjee R, Alaiti MA, Ramanan B, Modrall JG, Banerjee S, Tsai S
J Invasive Cardiol 2023 Jan;35(1):E31-E36. Epub 2022 Nov 30 PMID: 36446575
Midterm Results of the Supera Stent for the Treatment of Femoropopliteal Occlusive Disease.
Low J, Shih T, Lu E, Derubertis BG, Baril DT
Ann Vasc Surg 2022 Oct;86:177-183. Epub 2022 Jun 29 doi: 10.1016/j.avsg.2022.05.031. PMID: 35779806
The impact of inflow treatment for claudicants with both aortoiliac and femoropopliteal occlusive disease.
Maekawa T, Komori K, Kodama A, Banno H, Narita H, Sugimoto M
Surg Today 2017 Mar;47(3):293-300. Epub 2016 Sep 1 doi: 10.1007/s00595-016-1399-0. PMID: 27586013
Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials.
Acin F, de Haro J, Bleda S, Varela C, Esparza L
J Endovasc Ther 2012 Oct;19(5):585-95. doi: 10.1583/JEVT-12-3898R.1. PMID: 23046322
Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis.
Mwipatayi BP, Hockings A, Hofmann M, Garbowski M, Sieunarine K
J Vasc Surg 2008 Feb;47(2):461-9. Epub 2007 Oct 22 doi: 10.1016/j.jvs.2007.07.059. PMID: 17950563

Diagnosis

Drug-Eluting Balloon Therapy for Femoropopliteal Occlusive Disease: Predictors of Outcome With a Special Emphasis on Calcium.
Tepe G, Beschorner U, Ruether C, Fischer I, Pfaffinger P, Noory E, Zeller T
J Endovasc Ther 2015 Oct;22(5):727-33. Epub 2015 Aug 6 doi: 10.1177/1526602815600156. PMID: 26250747
Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW, Tran K, Itoga N, Casey K, Dalman RL, Lee JT
J Vasc Surg 2015 Jun;61(6):1479-88. Epub 2015 Feb 19 doi: 10.1016/j.jvs.2014.12.062. PMID: 25704407
The impact of sex on angioplasty and primary stenting for femoropopliteal occlusive disease: results of the DURABILITY II trial.
Tadros RO, Faries PL, Rocha-Singh KJ, Kim Sy, Malik RK, Ellozy SH, Marin ML, Vouyouka AG
Ann Vasc Surg 2014 Jan;28(1):1-9. Epub 2013 Nov 1 doi: 10.1016/j.avsg.2013.05.006. PMID: 24189009
Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies.
Vardi M, Novack V, Pencina MJ, Doros G, Burke DA, Elmariah S, Cutlip DE, Mauri L, Yeh RW
Catheter Cardiovasc Interv 2014 May 1;83(6):975-83. Epub 2014 Jan 31 doi: 10.1002/ccd.25179. PMID: 23996913
Femoropopliteal occlusive disease: diagnosis, indications for treatment, and results of interventional therapy.
Silver MJ, Ansel GM
Catheter Cardiovasc Interv 2002 Aug;56(4):555-61. doi: 10.1002/ccd.10217. PMID: 12124973

Therapy

Endovascular revascularization of TASC C and D femoropopliteal occlusive disease using carbon dioxide as contrast.
Mendes Cde A, Teivelis MP, Kuzniec S, Fukuda JM, Wolosker N
Einstein (Sao Paulo) 2016 Apr-Jun;14(2):124-9. doi: 10.1590/S1679-45082016AO3661. PMID: 27462884Free PMC Article
Drug-Eluting Balloon Therapy for Femoropopliteal Occlusive Disease: Predictors of Outcome With a Special Emphasis on Calcium.
Tepe G, Beschorner U, Ruether C, Fischer I, Pfaffinger P, Noory E, Zeller T
J Endovasc Ther 2015 Oct;22(5):727-33. Epub 2015 Aug 6 doi: 10.1177/1526602815600156. PMID: 26250747
Primary stenting in femoropopliteal occlusive disease - what is the appropriate role?
Yiu WK, Conte MS
Circ J 2015;79(4):704-11. Epub 2015 Mar 13 doi: 10.1253/circj.CJ-15-0199. PMID: 25766515
Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials.
Acin F, de Haro J, Bleda S, Varela C, Esparza L
J Endovasc Ther 2012 Oct;19(5):585-95. doi: 10.1583/JEVT-12-3898R.1. PMID: 23046322
Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis.
Mwipatayi BP, Hockings A, Hofmann M, Garbowski M, Sieunarine K
J Vasc Surg 2008 Feb;47(2):461-9. Epub 2007 Oct 22 doi: 10.1016/j.jvs.2007.07.059. PMID: 17950563

Prognosis

Management of isolated femoropopliteal in-stent restenosis.
Qato K, Conway AM, Mondry L, Giangola G, Carroccio A
J Vasc Surg 2018 Sep;68(3):807-810. doi: 10.1016/j.jvs.2018.01.030. PMID: 30144908
The impact of inflow treatment for claudicants with both aortoiliac and femoropopliteal occlusive disease.
Maekawa T, Komori K, Kodama A, Banno H, Narita H, Sugimoto M
Surg Today 2017 Mar;47(3):293-300. Epub 2016 Sep 1 doi: 10.1007/s00595-016-1399-0. PMID: 27586013
Drug-Eluting Balloon Therapy for Femoropopliteal Occlusive Disease: Predictors of Outcome With a Special Emphasis on Calcium.
Tepe G, Beschorner U, Ruether C, Fischer I, Pfaffinger P, Noory E, Zeller T
J Endovasc Ther 2015 Oct;22(5):727-33. Epub 2015 Aug 6 doi: 10.1177/1526602815600156. PMID: 26250747
Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease.
Vartanian SM, Johnston PC, Walker JP, Runge SJ, Eichler CM, Reilly LM, Hiramoto JS, Conte MS
J Vasc Surg 2013 Dec;58(6):1525-31. Epub 2013 Jul 30 doi: 10.1016/j.jvs.2013.05.094. PMID: 23911250
Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes.
Robinson WP 3rd, Nguyen LL, Bafford R, Belkin M
J Vasc Surg 2011 Mar;53(3):651-7. Epub 2010 Dec 3 doi: 10.1016/j.jvs.2010.09.020. PMID: 21129908

Clinical prediction guides

The impact of inflow treatment for claudicants with both aortoiliac and femoropopliteal occlusive disease.
Maekawa T, Komori K, Kodama A, Banno H, Narita H, Sugimoto M
Surg Today 2017 Mar;47(3):293-300. Epub 2016 Sep 1 doi: 10.1007/s00595-016-1399-0. PMID: 27586013
Endovascular revascularization of TASC C and D femoropopliteal occlusive disease using carbon dioxide as contrast.
Mendes Cde A, Teivelis MP, Kuzniec S, Fukuda JM, Wolosker N
Einstein (Sao Paulo) 2016 Apr-Jun;14(2):124-9. doi: 10.1590/S1679-45082016AO3661. PMID: 27462884Free PMC Article
Clinical Outcomes after Endovascular Treatment Failure in Patients with Femoropopliteal Occlusive Disease.
Hernández Mateo MM, Martínez López I, Revuelta Suero S, Marqués de Marino P, Cernuda Artero I, Cabrero Fernández M, Serrano Hernando FJ
Ann Vasc Surg 2016 Jan;30:299-304. Epub 2015 Nov 2 doi: 10.1016/j.avsg.2015.07.039. PMID: 26541966
Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease.
Vartanian SM, Johnston PC, Walker JP, Runge SJ, Eichler CM, Reilly LM, Hiramoto JS, Conte MS
J Vasc Surg 2013 Dec;58(6):1525-31. Epub 2013 Jul 30 doi: 10.1016/j.jvs.2013.05.094. PMID: 23911250
Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease.
Johnston PC, Vartanian SM, Runge SJ, Hiramoto JS, Eichler CM, Owens CD, Schneider DB, Conte MS
J Vasc Surg 2012 Oct;56(4):998-1006, 1007.e1; discussion 1006-7. Epub 2012 May 25 doi: 10.1016/j.jvs.2012.03.010. PMID: 22633429

Recent systematic reviews

Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
Caradu C, Lakhlifi E, Colacchio EC, Midy D, Bérard X, Poirier M, Ducasse E
J Vasc Surg 2019 Sep;70(3):981-995.e10. Epub 2019 May 21 doi: 10.1016/j.jvs.2019.01.080. PMID: 31126769
Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies.
Vardi M, Novack V, Pencina MJ, Doros G, Burke DA, Elmariah S, Cutlip DE, Mauri L, Yeh RW
Catheter Cardiovasc Interv 2014 May 1;83(6):975-83. Epub 2014 Jan 31 doi: 10.1002/ccd.25179. PMID: 23996913
Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis.
Mwipatayi BP, Hockings A, Hofmann M, Garbowski M, Sieunarine K
J Vasc Surg 2008 Feb;47(2):461-9. Epub 2007 Oct 22 doi: 10.1016/j.jvs.2007.07.059. PMID: 17950563

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...